technicalsymposium

Free E-Mail Alerts

27th Asian Pacific Association for the Study of the Liver (APASL 2018) Hepatology-The Next Genre that will be held from March 14 to 18, 2018 in New Delhi, India..

27th Asian Pacific Association for the Study of the Liver (APASL 2018) Hepatology-The Next Genre that will be held from March 14 to 18, 2018 in New Delhi, India..

It is a great pleasure for us to invite you to the 27th Asian Pacific Association for the Study of the Liver (APASL 2018) that will be held from March 14 to 18, 2018 in New Delhi, India.. We are delighted to welcome you to the cultural and historical metropolis of New Delhi.

The conference program will have high quality content with up-to-date information by eminent researchers and clinicians, covering all aspects of Hepatology.

The conference will provide an avenue for cooperation and collaboration amongst various institutions, academicia, companies, associations, non-profit organizations, and other related sectors, to deliver benefits to the people in the Asian Pacific region, where liver disease continues to be a major problem area.

This would be the perfect opportunity for all of us to share our views, values, experiences and practices regarding liver diseases, such as Viral Hepatitis, Liver Cancers, NASH, Liver Failure, Portal hypertension, Alcoholic Liver Disease, Liver Transplantation, Pediatric Liver Diseases, Liver Radiology, and other topics.

Abstracts must be submitted electronically via the conference website. No faxed or mailed abstracts will be accepted. There are no exceptions to the deadline as the review period ensues immediately after the submission site closes.



Official Language

All presentations at APASL Annual Meeting 2018 will be in English.

Submission Categories

Authors must select a submissions category when submitting their abstract. Please find the below Full List Of Abstract Submission Categories:

Acute Liver Failure and Artificial Liver Support-Clinical

• CA-01 Acute Liver Failure and Artificial Liver Support-Clinical

Acute Liver Failure and Artificial Liver Support- Basic

• BA-01 Acute Liver Failure and Artificial Liver Support-Basic Science

Alcoholic Liver Disease-Clinical

• CAL-01 Alcoholic Liver Disease: Clinical and Therapeutic

Alcoholic Liver Disease-Basic

• BAL-01 Alcoholic Liver Disease: Experimental

Hepatitis B and D-Clinical

• CB-01 Diagnostics, Epidemiology, Prevention, Natural History

• CB-02 Therapeutics: New and Approved

Hepatitis B and D-Basic • BB-01 Virology, Pathogenesis, and Immunology

Biliary and pancreatic Neoplasia other than Liver cancer-Clinical

• CBN-01 Diagnostics and Liver Imaging of biliary and pancreatic neoplasia

• CBN-02 Prognosis : biliary and pancreatic neoplasia

• CBN-03 Surgery and Loco-Regional Therapy for biliary and pancreatic neoplasia

• CBN-04 Targetted and systemic therapies for biliary and pancreatic neoplasia

Biliary and pancreatic Neoplasia other than Liver cancer-Basic

• BBN-01 Experimental carcinogenesis of biliary and pancreatic neoplasia

Hepatitis C-Clinical

• CC-01 Diagnostics, Epidemiology, Natural History

• CC-02 Therapeutics: Preclinical and Early Clinical Development

• CC-03 Therapeutics: New Agents (not approved, phase 2-3)

• CC-04 Therapeutics: Approved Agents

Hepatitis C-Basic

• BC-01 Virology, Pathogenesis, and Immunology

Cholestatic and Autoimmune Liver Diseases-Clinical

• CCA-01 PBC/PSC and Other Cholestatic Disease: Clinical and Therapeutics

• CCA-02 Autoimmune Liver Disease: Clinical and Therapeutics

Cholestatic and Autoimmune Liver Diseases-Basic

• BCA-01 Transport, Bilirubin, Cholesterol, Lipids and Bile Salts, Cholangiocyte Biology and Experimental Cholestasis

• BCA-02 Autoimmune Liver Disease:Experimental

Drug Induced Liver Injury-Clinical

• CD-01 Predictors of Drug Toxicity and Therapy

Drug Induced Liver Injury-Basic

• BD-01 Pathogenesis and Mechanisms

• BD-02 Drug Metabolism, and Toxicity

Hepatitis A and E-Clinical

• CE-01 Hepatitis A and E- Clinical and Therapeutic

Hepatitis A and E-Basic

• BE-01 Hepatitis A and Experimental

Liver Fibrogenesis and Non-Parenchymal Cell Biology-Clinical

• BF-01 Imaging and Noninvasive Markers of Liver Fibrosis

• BF-02 Clinical and Translational Fibrosis Research and Therapy

Liver Fibrogenesis and Non-Parenchymal Cell Biology-Basic

• BF-01 Basic Fibrosis Research and Stellate Cell Biology

Genetic and Metabolic Disease-Clinical

• CG-01 Hemochromatosis, Wilson Disease, ?-1 Antitrypsin Deficiency-Clinical

• CG-02 Other genetic and metabolic disorders-Clinical

Genetic and Metabolic Disease-Basic

• BG-01 Hemochromatosis, Wilson Disease, ?-1 Antitrypsin Deficiency-Experimental

• BG-02 Other genetic and metabolic disorders-Experimental

Abstract Title

There is a limit of 300 characters, including spaces, for the title of an abstract.



Authors

Please list all authors with their affiliations (institution, city and country).

Authorship

Credit for authorship requires substantial contributions to the conception and design; or the acquisition, analysis, or interpretation of the data, final approval of the version to be published, and agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved.

Abstract Body

There is a limit of 3000 characters, including spaces, for the body of abstract submissions. Abstract titles, author names, author institutions, and information in tables and images do not count toward the 3000 character limit. Abstract text for original article should include 1) background/aims, 2) methods, 3) results and 4) conclusions. For case report, it should include introduction and case description. Do not include references and key words in the abstract.

Tables and Figures

A maximum of 2 images can be included per abstract. The maximum file size of each graph/image is 2M. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. Graphs and images may be uploaded in JPG, PNG and GIF format only. When including a table it is recommended to save the table as an image and then upload it in to the abstract.

Format Use the abbreviation in parentheses after the full word the first time it appears. To avoid character corruption, please use only Times New Roman font. Font size should be 10.

Editing A Submitted Abstract Authors may edit submitted abstracts until the submissions deadline. Abstract submitters should log into their registration account to make any edits.

Conference Secretariat

Conference Manager

Institute of Liver and Biliary Sciences D-1 Vasant Kunj, New Delhi - 110070, India

Email: info@apasl2018.in

Website: www.apasl2018.in

Contact Person:

Dr. Barjesh C Sharma

Organizing Secretary

Mob.: +91-9540951000

Dr. Manoj K Sharma

President

Mob.: +91-9313416555

Dr. Rakhi Maiwall

Treasurer

Mob.: +91-8750343085

View Conference (Event Website) Details




Source:Admin

Free Projects
Java Projects
Engineering Projects
Science Projects
Bio Sensors
Cloud Computing
Cluster Computing
Data mining
Mobile Computing
Neural Networks
Sun Java Certifications
Red Hat Certifications
Oracle Certifications
Cisco Certifications
Microsoft Certifications
SAP Certifications
Free Projects
Java Projects
Engineering Projects
Science Projects
Bio Sensors
Cloud Computing
Cluster Computing
Data mining
SQL Server 2008 Training
ASP.NET Grid and Editors-Advanced grid
C,C Aptitude Questions,Aptitude Questions in C
Virtual Server
Linux Hosting
Study Abroad
MicroHosting
C/C++/.NET/Oracle Projects
Wipro Placement Papers
TCS Placement Papers
Infosys Placement Papers
Syntel Placement Papers
I-Gate Placement Papers
Bio Sensors
Cloud Computing
Cluster Computing
Data mining
SQL Server 2008 Training
ASP.NET Grid and Editors-Advanced grid
C,C Aptitude Questions,Aptitude Questions in C
Virtual Server
Linux Hosting
Study Abroad
MicroHosting
C/C++/.NET/Oracle Projects
Wipro Placement Papers
TCS Placement Papers
Infosys Placement Papers
Syntel Placement Papers
I-Gate Placement Papers

Hosting by Yahoo!

About-Us    Contact-Us    Site-map

©copyright All rights are reserved to technicalsymposium.com